Oppenheimer Assigns Outperform On HCA Holdings, $84 PT
In a research report issued today, Oppenheimer analyst Michael Wiederhorn assigned an Outperform rating on HCA Holdings Inc (NYSE:HCA) with a price target of $84.00.
Wiederhorn noted, “HCA reported Q3:14 adjusted EPS of $1.18, in line with the company’s pre- announcement and well ahead of prior Street estimates. HCA’s adjusted EPS does include $0.04/share from a $26M net gain related to prior-period revenues (+94M RAC settlement, -$68M TX Medicaid Wavier). The results were driven by robust adj- admissions growth of +4.1%. Given the company’s updated guidance of $4.40-$4.60 (vs $4.00-$4.25), we are raising our FY2014 and FY2015 EPS estimates to $4.56 and $4.85, from $4.16 and $4.38, and raising our price target to $84 from $74.”
According to TipRanks.com, which measures analysts’ and bloggers’ success rate based on how their calls perform, analyst Michael Wiederhorn has a total average return of 19.7% and a 85.4% success rate. Wiederhorn has a 24.0% average return when recommending HCA, and is ranked #98 out of 3350 analysts.